Evicenter
Trodelvy (sacituzumab govitecan-hziy) in Metastatic triple-negative breast cancer
Manufacturer
Gilead Sciences, Inc.
Prescribing information
Trodelvy (opens in a new tab)
Questions
47
Last updated

All questions

Access and coverage: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer

7 questions · 3 sources

Access and billing

What is the NDC for TRODELVY?

Access and support

Does TRODELVY have copay or patient assistance programs?

Note: The first passage is from the Commercial or Private tab of the Financial Assistance page and the second from its Government tab; the third is the support-request section of the Gilead Oncology Support enrollment form that the resources library links. The page's No Insurance tab was not captured, so assistance for uninsured patients is not quoted.

What is the J-code for TRODELVY?

How do you contact TRODELVY reimbursement support?

Cost and coverage

How much does TRODELVY cost with the Gilead Oncology Co-pay Program?

Can Medicare patients get help paying for TRODELVY?

Note: The first passage describes the Gilead Oncology Co-pay Program for commercially insured patients; the others appear under the Government tab of the same page.

Prior authorization

Is TRODELVY prior authorization and appeals information available?